A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer

  • M. A. Socinski
  • , A. Ivanova
  • , K. Bakri
  • , J. Wall
  • , M. Q. Baggstrom
  • , T. A. Hensing
  • , A. Mears
  • , M. Tynan
  • , J. Beaumont
  • , A. H. Peterman
  • , H. B. Niell

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science